Literature DB >> 28822832

Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1.

Craig D Platt1, Ari J Fried1, Rodrigo Hoyos-Bachiloglu1, G Naheed Usmani2, Birgitta Schmidt3, Jennifer Whangbo4, Roberto Chiarle3, Janet Chou1, Raif S Geha5.   

Abstract

RASGRP1 is a guanine-nucleotide-exchange factor essential for MAP-kinase mediated signaling in lymphocytes. We report the second case of RASGRP1 deficiency in a patient with a homozygous nonsense mutation in the catalytic domain of the protein. The patient had epidermodysplasia verruciformis, suggesting a clinically important intrinsic T cell function defect. Like the previously described patient, our proband also presented with CD4+ T cell lymphopenia, impaired T cell proliferation to mitogens and antigens, reduced NK cell function, and EBV-associated lymphoma. The severity of the disease and the development of EBV lymphoma in both patients suggest that hematopoietic stem cell transplantation should be performed rapidly in patients with RASGRP1 deficiency.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidermodysplasia verruciformis; Epstein Barr Virus; Lymphoma; RASGRP1 deficiency

Mesh:

Substances:

Year:  2017        PMID: 28822832      PMCID: PMC5673555          DOI: 10.1016/j.clim.2017.08.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  RasGRP: the missing link for Ras activation in thymocytes.

Authors:  K Hogquist
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

2.  Multiple checkpoint breach of B cell tolerance in Rasgrp1-deficient mice.

Authors:  Amber Bartlett; Janet E Buhlmann; James Stone; Bing Lim; Robert A Barrington
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

Review 3.  Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.

Authors:  Joanna Przybyszewska; Abraham Zlotogorski; Yuval Ramot
Journal:  J Am Acad Dermatol       Date:  2017-02-10       Impact factor: 11.527

4.  RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling.

Authors:  Jason J Coughlin; Stacey L Stang; Nancy A Dower; James C Stone
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  Epidermodysplasia verruciformis as a manifestation of ARTEMIS deficiency in a young adult.

Authors:  Azzedine Tahiat; Yousef R Badran; Janet Chou; Brittney Cangemi; Gerard Lefranc; Zakaria-Merouane Labgaa; Salma Oussalam; Assia Kaddouri-Slimani; Ayad Belarbi; Kheira Bendissari-Bouzid; Merzak Gharnaout; Raif S Geha; Réda Djidjik; Michel J Massaad
Journal:  J Allergy Clin Immunol       Date:  2016-08-24       Impact factor: 10.793

6.  RasGRP is essential for mouse thymocyte differentiation and TCR signaling.

Authors:  N A Dower; S L Stang; D A Bottorff; J O Ebinu; P Dickie; H L Ostergaard; J C Stone
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

7.  RasGRP1 is required for human NK cell function.

Authors:  Suk Hyung Lee; Sohyun Yun; Jiwon Lee; Mi Jeong Kim; Zheng-Hao Piao; Mira Jeong; Jin Woong Chung; Tae-Don Kim; Suk Ran Yoon; Philip D Greenberg; Inpyo Choi
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 8.  Primary immunodeficiencies and the control of Epstein-Barr virus infection.

Authors:  Umaimainthan Palendira; Alan B Rickinson
Journal:  Ann N Y Acad Sci       Date:  2015-09-28       Impact factor: 5.691

9.  RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics.

Authors:  Elisabeth Salzer; Deniz Cagdas; Miroslav Hons; Emily M Mace; Wojciech Garncarz; Özlem Yüce Petronczki; René Platzer; Laurène Pfajfer; Ivan Bilic; Sol A Ban; Katharina L Willmann; Malini Mukherjee; Verena Supper; Hsiang Ting Hsu; Pinaki P Banerjee; Papiya Sinha; Fabienne McClanahan; Gerhard J Zlabinger; Winfried F Pickl; John G Gribben; Hannes Stockinger; Keiryn L Bennett; Johannes B Huppa; Loïc Dupré; Özden Sanal; Ulrich Jäger; Michael Sixt; Ilhan Tezcan; Jordan S Orange; Kaan Boztug
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

  9 in total
  17 in total

Review 1.  mTOR and other effector kinase signals that impact T cell function and activity.

Authors:  Darienne R Myers; Benjamin Wheeler; Jeroen P Roose
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

2.  Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.

Authors:  Leila Youssefian; Hassan Vahidnezhad; Mehdi Yousefi; Amir Hossein Saeidian; Arghavan Azizpour; Andrew Touati; Neda Nikbakht; Kambiz Kamyab- Hesari; Mohammad Mahdi Adib-Sereshki; Sirous Zeinali; Behzad Mansoori; Ali Jazayeri; Razieh Karamzadeh; Paolo Fortina; Emmanuelle Jouanguy; Jean-Laurent Casanova; Jouni Uitto
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

Review 3.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

Review 4.  Defects of the Innate Immune System and Related Immune Deficiencies.

Authors:  Nicole Akar-Ghibril
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-21       Impact factor: 10.817

5.  Identifying Potential Effective Diagnostic and Prognostic Biomarkers in Sepsis by Bioinformatics Analysis and Validation.

Authors:  Xu Huang; Jixiang Tan; Xiaoying Chen; Lin Zhao
Journal:  Int J Gen Med       Date:  2022-07-06

6.  Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.

Authors:  Ido Somekh; Benjamin Marquardt; Yanshan Liu; Meino Rohlfs; Sebastian Hollizeck; Musa Karakukcu; Ekrem Unal; Ebru Yilmaz; Turkan Patiroglu; Murat Cansever; Shirly Frizinsky; Vicktoria Vishnvenska-Dai; Erez Rechavi; Tali Stauber; Amos J Simon; Atar Lev; Christoph Klein; Daniel Kotlarz; Raz Somech
Journal:  J Clin Immunol       Date:  2018-07-20       Impact factor: 8.317

7.  Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.

Authors:  Sarah Winter; Emmanuel Martin; David Boutboul; Christelle Lenoir; Sabah Boudjemaa; Arnaud Petit; Capucine Picard; Alain Fischer; Guy Leverger; Sylvain Latour
Journal:  EMBO Mol Med       Date:  2018-02       Impact factor: 12.137

8.  Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.

Authors:  Sarah J de Jong; Elias Imahorn; Peter Itin; Jouni Uitto; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova; Bettina Burger
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

9.  Nurr1 performs its anti-inflammatory function by regulating RasGRP1 expression in neuro-inflammation.

Authors:  Mihee Oh; Sun Young Kim; Jung-Eun Gil; Jeong-Su Byun; Dong-Wook Cha; Bonsu Ku; Woonghee Lee; Won-Kon Kim; Kyoung-Jin Oh; Eun-Woo Lee; Kwang-Hee Bae; Sang Chul Lee; Baek-Soo Han
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

Review 10.  Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?

Authors:  Sujal Ghosh; Ingo Drexler; Sanil Bhatia; Heiko Adler; Andrew R Gennery; Arndt Borkhardt
Journal:  Front Immunol       Date:  2018-05-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.